A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...

This Research Topic is part of the Insights in Experimental Pharmacology and Drug Discovery series. You can explore the ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

NVIDIA CEO says AI will revolutionize drug research, promising major breakthroughs in the pharma industry. Speaking at the ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Florida State University is looking to participate in what could be a groundbreaking drug discovery study through a ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion into Taiwan further underscores the Company’s accelerating global adoption and ...

STOCKHOLM, July 16, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research for lecanemab (product name Leqembi®), an ...